日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules

rucaparib 的肿瘤细胞保留、持续 PARP 抑制以及每周和每日给药方案的疗效

J Murray, H Thomas, P Berry, S Kyle, M Patterson, C Jones, G Los, Z Hostomsky, E R Plummer, A V Boddy, N J Curtin